Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Tag: GMP inspections

The Importance of PMDA GMP in Managing Pharmaceutical Manufacturing Risks

Posted on January 5, 2025 By digi

The Importance of PMDA GMP in Managing Pharmaceutical Manufacturing Risks The Importance of PMDA GMP in Managing Pharmaceutical Manufacturing Risks Introduction to PMDA GMP and Risk Management in Pharmaceutical Manufacturing Pharmaceutical manufacturing is an intricate process that involves numerous risks, from raw material sourcing to final product distribution. These risks can include contamination, equipment failures,…

Read More “The Importance of PMDA GMP in Managing Pharmaceutical Manufacturing Risks” »

PMDA GMP Guidelines

Understanding the FDA’s 21 CFR Part 210 and 211 GMP Guidelines

Posted on January 4, 2025 By digi

Understanding the FDA’s 21 CFR Part 210 and 211 GMP Guidelines Comprehensive Guide to FDA’s 21 CFR Part 210 and 211 GMP Guidelines Introduction to 21 CFR Part 210 and 211 The U.S. Food and Drug Administration (FDA) has established stringent regulations to ensure the safety, quality, and efficacy of pharmaceutical products. The Good Manufacturing…

Read More “Understanding the FDA’s 21 CFR Part 210 and 211 GMP Guidelines” »

FDA GMP Guidelines

A Guide to Achieving Health Canada GMP Compliance in Pharma

Posted on January 4, 2025 By digi

A Guide to Achieving Health Canada GMP Compliance in Pharma Comprehensive Guide to Achieving Health Canada GMP Compliance for Pharmaceutical Manufacturers Introduction to Health Canada GMP Compliance Achieving compliance with Health Canada’s Good Manufacturing Practices (GMP) regulations is a crucial milestone for pharmaceutical manufacturers operating in or exporting to Canada. These regulations set rigorous standards…

Read More “A Guide to Achieving Health Canada GMP Compliance in Pharma” »

Health Canada GMP Regulations

How to Address Non-Conformities Identified During Schedule M (Revised) Inspections

Posted on January 4, 2025 By digi

How to Address Non-Conformities Identified During Schedule M (Revised) Inspections Effective Strategies to Resolve Non-Conformities in Schedule M (Revised) GMP Inspections Introduction to Non-Conformities in GMP Inspections Non-conformities identified during Schedule M (Revised) inspections can significantly impact pharmaceutical manufacturing operations. These findings, which highlight deviations from Good Manufacturing Practices (GMP), pose risks to product quality,…

Read More “How to Address Non-Conformities Identified During Schedule M (Revised) Inspections” »

SCHEDULE - M - Revised

How NMPA GMP Promotes the Use of Advanced Technology in Pharmaceutical Manufacturing

Posted on January 4, 2025 By digi

How NMPA GMP Promotes the Use of Advanced Technology in Pharmaceutical Manufacturing How NMPA GMP Promotes the Use of Advanced Technology in Pharmaceutical Manufacturing Introduction to NMPA GMP and Technological Advancements As the pharmaceutical industry continues to grow and evolve, there is an increasing reliance on advanced technology to meet the rising demand for high-quality,…

Read More “How NMPA GMP Promotes the Use of Advanced Technology in Pharmaceutical Manufacturing” »

NMPA GMP Guidelines

The Impact of PMDA GMP Compliance on Pharma Product Launches

Posted on January 4, 2025 By digi

The Impact of PMDA GMP Compliance on Pharma Product Launches The Impact of PMDA GMP Compliance on Pharma Product Launches Introduction to PMDA GMP and Product Launches The pharmaceutical industry is a highly regulated sector, with strict guidelines in place to ensure that drugs are safe, effective, and manufactured under controlled conditions. In Japan, the…

Read More “The Impact of PMDA GMP Compliance on Pharma Product Launches” »

PMDA GMP Guidelines

How to Achieve FDA GMP Compliance for Drug Development

Posted on January 4, 2025 By digi

How to Achieve FDA GMP Compliance for Drug Development Achieving FDA GMP Compliance in Drug Development: A Comprehensive Guide Introduction to FDA GMP Compliance The journey from concept to market for a pharmaceutical product is long and complex, requiring strict adherence to quality standards at every stage. The U.S. Food and Drug Administration (FDA)’s Good…

Read More “How to Achieve FDA GMP Compliance for Drug Development” »

FDA GMP Guidelines

How Health Canada GMP Regulations Ensure Drug Safety and Quality

Posted on January 4, 2025 By digi

How Health Canada GMP Regulations Ensure Drug Safety and Quality How Health Canada GMP Regulations Safeguard Drug Safety and Quality Introduction to Health Canada GMP Ensuring drug safety and quality is a cornerstone of the pharmaceutical industry, directly impacting patient health and public trust. Health Canada’s Good Manufacturing Practices (GMP) regulations are a critical framework…

Read More “How Health Canada GMP Regulations Ensure Drug Safety and Quality” »

Health Canada GMP Regulations

How NMPA GMP Affects the Cost and Efficiency of Pharmaceutical Manufacturing

Posted on January 4, 2025 By digi

How NMPA GMP Affects the Cost and Efficiency of Pharmaceutical Manufacturing How NMPA GMP Affects the Cost and Efficiency of Pharmaceutical Manufacturing Introduction to NMPA GMP and Pharmaceutical Manufacturing The pharmaceutical industry faces growing pressure to produce safe, effective, and high-quality products while keeping costs manageable and improving operational efficiency. In China, the National Medical…

Read More “How NMPA GMP Affects the Cost and Efficiency of Pharmaceutical Manufacturing” »

NMPA GMP Guidelines

Best Practices for Compliance with Schedule M (Revised) GMP in Biopharmaceuticals

Posted on January 4, 2025 By digi

Best Practices for Compliance with Schedule M (Revised) GMP in Biopharmaceuticals Ensuring Compliance with Schedule M (Revised) GMP in Biopharmaceutical Manufacturing Introduction to Biopharmaceuticals and GMP Compliance Biopharmaceuticals represent a rapidly growing segment of the pharmaceutical industry, offering innovative therapies for complex diseases such as cancer, autoimmune disorders, and genetic conditions. However, their production involves…

Read More “Best Practices for Compliance with Schedule M (Revised) GMP in Biopharmaceuticals” »

SCHEDULE - M - Revised

Posts pagination

Previous 1 … 10 11 12 … 50 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme